Advancing T-Cell-Targeted Therapies for Autoimmune Diseases to Unlock More Precise & Durable Treatment Options
Time: 1:10 pm
day: Conference Day One Teal Track P2
Details:
- Explore T-cell targeting strategies to combat SLE and improve therapeutic outcomes
- Examining Novartis’ srSLE CAR-T data to uncover insights into novel CAR-T approaches to address unmet medical needs
- Highlight Novartis’ novel CAR-T manufacturing platform (T-Charge) to evaluate its impact on enhancing T-cell targeted treatments for autoimmune diseases
Speakers:
